Correlation Between Telix Pharmaceuticals and Manhattan Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Manhattan Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Manhattan Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Manhattan Corp, you can compare the effects of market volatilities on Telix Pharmaceuticals and Manhattan Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Manhattan Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Manhattan Corp.

Diversification Opportunities for Telix Pharmaceuticals and Manhattan Corp

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Telix and Manhattan is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Manhattan Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Manhattan Corp and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Manhattan Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Manhattan Corp has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Manhattan Corp go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Manhattan Corp

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 5.22 times less return on investment than Manhattan Corp. But when comparing it to its historical volatility, Telix Pharmaceuticals is 14.52 times less risky than Manhattan Corp. It trades about 0.21 of its potential returns per unit of risk. Manhattan Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  3.00  in Manhattan Corp on September 27, 2024 and sell it today you would lose (0.90) from holding Manhattan Corp or give up 30.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Manhattan Corp

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Manhattan Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Manhattan Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Manhattan Corp unveiled solid returns over the last few months and may actually be approaching a breakup point.

Telix Pharmaceuticals and Manhattan Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Manhattan Corp

The main advantage of trading using opposite Telix Pharmaceuticals and Manhattan Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Manhattan Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manhattan Corp will offset losses from the drop in Manhattan Corp's long position.
The idea behind Telix Pharmaceuticals and Manhattan Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings